Tilray Wins Monumental Price Aim Improve From This Analyst

Roth Capital Markets analyst Bill Kirk talked about in an Oct. 10 report that Tilray Producers (Tilray Producers Stock Quote, Chart, Data, Analysts, Financials NASDAQ:TLRY) delivered fiscal Q1/F26 outcomes that exceeded revenue expectations nevertheless obtained right here in precisely gentle on profitability as export permitting delays in Portugal continued to weigh on worldwide product sales.

Kirk maintained his “Neutral” rating and raised his 12-month purpose price to US$2.00 from US$0.60.

Tilray reported internet product sales of US$209.5-million, ahead of consensus at US$205.5-million nevertheless down from US$224.5-million throughout the prior quarter. Adjusted EBITDA was US$10.2-million, beneath consensus of US$10.8-million and down from US$27.6-million in This fall/F25. Gross margin of 27.4% declined 240 basis components 12 months over 12 months and 270 sequentially, largely on account of lower-margin worldwide product sales. The company reaffirmed its fiscal 2026 Adjusted EBITDA steering of US$62–72-million, which compares to consensus at roughly US$64.9-million and a fiscal 2025 base of US$55-million.

“Permitting factors in Portugal appear like enhancing, with Tilray receiving the similar number of licenses over the earlier two weeks as a result of it had throughout the earlier two months,” Kirk talked about.

He well-known that whereas these disruptions might also affect Q2 outcomes, for which he forecasts Adjusted EBITDA of US$7.2-million on US$209.4-million in product sales, the company’s core Canadian enterprise stays resilient.

“The Canadian adult-use section led the quarter, with volumes up 6.5% and pricing up 2% versus enterprise averages of -1.3%,” he talked about.

Part outcomes confirmed cannabis revenue of US$64.1-million, up from US$58.4-million in This fall/F25 and US$57.2-million in Q1/F25, offsetting weaker worldwide product sales, which fell to US$13.4-million from US$22.4-million throughout the prior quarter. Cannabis gross margin dropped to 36.1% from 43.7% in This fall. Beverage revenue of US$55.7-million was flat 12 months over 12 months nevertheless down sequentially from US$65.6-million as a result of the enterprise continued SKU rationalization. Beverage margins have been 38.3%, down barely from 41.0% ultimate 12 months. Distribution revenue remained common at US$74.0-million, in distinction with US$74.1-million in This fall/F25.

Tilray posted constructive internet earnings of US$1.5-million, supported by tax receipts of US$2.3-million and continued worth administration. Kirk talked about the company’s SKU rationalization and ongoing effectivity initiatives are enhancing profitability while worldwide logistics rapidly constrain improvement.

Kirk talked about Tilray must generate US$60.1-million in Adjusted EBITDA on US$862.8-million in revenue in fiscal 2026, in distinction with prior estimates of US$64.0-million on US$868.1-million.

He added that upside for the stock “might be predominantly determined by U.S. legislative outcomes,” noting that Tilray shares have risen about 230% before now three months in distinction with a 7% obtain throughout the S&P 500.

“Tilray’s publicity to the U.S. would rely intently on how regulatory modifications are structured and its ability to compete with established players,” Kirk talked about. “Nonetheless, the company’s core fundamentals are enhancing, supported by a safe cannabis pricing ambiance, enhancing beer profitability, and a useful supply-demand stability in Germany.”

-30-